Irritable Bowel Syndrome Trial, Recruiting NCT05808036 Sponsor: Universitaire Ziekenhuizen KU Leuven Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Irritable Bowel Syndrome Trial, Recruiting

NCT05808036
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing to take part and have given your written agreement to join before any checks begin.
  • You are using a reliable form of birth control (such as implants, injections, the pill, certain coils, or complete abstinence from sex) or have a partner who has had a vasectomy.
  • You have been diagnosed with irritable bowel syndrome (IBS) based on a specific set of recognised medical guidelines called the Rome IV criteria.
  • You are between 18 and 70 years old.

Who may not be able to join:

  • You have a history of a serious mental health condition, depression, or alcohol or drug misuse in the last 2 years.
  • You have any other health condition that the trial doctor feels could put you at risk or make it hard for you to follow the trial rules.
  • You are currently having, or have previously had, any treatment that the trial doctor believes could affect your safety or the results of the trial.
  • You are pregnant, breastfeeding, planning to become pregnant, or could become pregnant and are not using a reliable form of birth control.
  • You are currently taking part in another clinical trial involving a medical treatment or device.
  • Your main symptoms are related to functional dyspepsia (persistent stomach pain or discomfort unrelated to IBS) or acid reflux disease (confirm with trial site).
  • You are following a special diet that the trial doctor believes would interfere with the diet used in this study.
  • You have already tried the low FODMAP diet (a specific eating plan for digestive symptoms) with the help of a trained dietitian and it did not help you.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 016344225

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 April 2023
Est. completion
1 August 2026

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Symptom response DOMINO app and low FODMAP diet

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov